ENTRY       D02109                      Drug
NAME        dl-Methylephedrine hydrochloride (JP18);
            Methy-F (TN)
FORMULA     C11H17NO. HCl
EXACT_MASS  215.1077
MOL_WEIGHT  215.7197
CLASS       Cardiovascular agent
             DG01456  Adrenergic receptor agonist
REMARK      Same as: C13639
            Therapeutic category: 2221
            Chemical structure group: DG01229
            Product (DG01229): D02109<JP>
            Product (mixture): D04313<JP> D04342<JP> D08695<JP>
EFFICACY    Antitussive, Bronchodilator, Adrenergic receptor agonist
COMMENT     Phenethylamine derivative
TARGET      ADRA1 [HSA:148 147 146] [KO:K04135 K04136 K04137]
            ADRA2 [HSA:150 151 152] [KO:K04138 K04139 K04140]
            ADRB [HSA:153 154 155] [KO:K04141 K04142 K04143]
  PATHWAY   hsa04020(146+147+148+153+154+155)  Calcium signaling pathway
            hsa04080(146+147+148+150+151+152+153+154+155)  Neuroactive ligand-receptor interaction
            hsa04261(146+147+148+153+154)  Adrenergic signaling in cardiomyocytes
            hsa04270(146+147+148)  Vascular smooth muscle contraction
            hsa04970(146+147+148+153+154+155)  Salivary secretion
INTERACTION  
BRITE       Therapeutic category of drugs in Japan [BR:br08301]
             2  Agents affecting individual organs
              22  Respiratory organ agents
               222  Antitussives
                2221  Ephedrines and Ephedra herbs
                 D02109  dl-Methylephedrine hydrochloride (JP18)
            Classification of Japanese OTC drugs [BR:br08313]
             Agents for nervous and sensory systems
              01 Cold remedy (oral use)
               D02109  dl-Methylephedrine hydrochloride (JP18)
             Agents for respiratory organs
              26 Antitussives and expectorants
               D02109  dl-Methylephedrine hydrochloride (JP18)
             Agents for  urogenital organs and anus
              30 Hemorrhoid drugs for external use
               D02109  dl-Methylephedrine hydrochloride (JP18)
             Agents for otolaryngologic use
              69 Oral medicine for nasal inflammation
               D02109  dl-Methylephedrine hydrochloride (JP18)
            Risk category of Japanese OTC drugs [BR:br08312]
             Designated second-class OTC drugs
              Inorganic and organic chemicals
               Methylephedrine
                D02109  dl-Methylephedrine hydrochloride (JP18)
             Second-class OTC drugs
              Inorganic and organic chemicals
               Methylephedrine
                D02109  dl-Methylephedrine hydrochloride (JP18)
            Drug groups [BR:br08330]
             Cardiovascular agent
              DG01456  Adrenergic receptor agonist
               DG01229  Methylephedrine
                D02109  dl-Methylephedrine hydrochloride
            Target-based classification of drugs [BR:br08310]
             G Protein-coupled receptors
              Rhodopsin family
               Adrenaline
                ADRA1
                 D02109  dl-Methylephedrine hydrochloride (JP18) &lt;JP&gt;
                ADRA2
                 D02109  dl-Methylephedrine hydrochloride (JP18) &lt;JP&gt;
                ADRB
                 D02109  dl-Methylephedrine hydrochloride (JP18) &lt;JP&gt;
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D02109  dl-Methylephedrine hydrochloride
              D02109  10% dl-Methylephedrine hydrochloride powder
            Narcotics and psychotropics in Japan [br08308.html]
             Stimulants by Control Act Article 2 Appended Table and Cabinet Order
              D02109
            Drug groups [BR:br08330]
             Cardiovascular agent
              DG01456  Adrenergic receptor agonist
               DG01229  Methylephedrine
DBLINKS     CAS: 18760-80-0
            PubChem: 7849170
            ChEBI: 79398
            LigandBox: D02109
            NIKKAJI: J237.399H
ATOM        14
            1   C8x C    27.6287  -17.1735
            2   C8x C    27.6287  -18.5731
            3   C8x C    28.8416  -19.2728
            4   C8x C    30.0545  -18.5731
            5   C8y C    30.0545  -17.1735
            6   C8x C    28.8416  -16.4738
            7   C1c C    31.2674  -16.4738
            8   C1c C    32.4804  -17.1735
            9   N1c N    33.6933  -16.4738
            10  C1a C    34.9062  -17.1735
            11  C1a C    32.4804  -18.5731
            12  O1a O    31.2674  -15.0743
            13  C1a C    33.6933  -15.0743
            14  X   Cl   39.4336  -16.9402
BOND        13
            1     1   2 2
            2     2   3 1
            3     3   4 2
            4     4   5 1
            5     5   6 2
            6     1   6 1
            7     5   7 1
            8     7   8 1
            9     8   9 1
            10    9  10 1
            11    8  11 1
            12    7  12 1
            13    9  13 1
///
